These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25343158)

  • 1. Clinical inquiry. What treatments relieve arthritis and fatigue associated with systemic lupus erythematosus?
    Jones DW; Wright D; Jankowski TA
    J Fam Pract; 2014 Oct; 63(10):607-17. PubMed ID: 25343158
    [No Abstract]   [Full Text] [Related]  

  • 2. Etanercept in refractory lupus arthritis: An observational study.
    Cortés-Hernández J; Egri N; Vilardell-Tarrés M; Ordi-Ros J
    Semin Arthritis Rheum; 2015 Jun; 44(6):672-9. PubMed ID: 25712812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.
    Abarientos C; Sperber K; Shapiro DL; Aronow WS; Chao CP; Ash JY
    Expert Opin Drug Saf; 2011 Sep; 10(5):705-14. PubMed ID: 21417950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxychloroquine and lupus flare: a good drug, but we need to do better.
    Crow MK; Kirou KA
    Ann Rheum Dis; 2022 Mar; 81(3):303-305. PubMed ID: 35039325
    [No Abstract]   [Full Text] [Related]  

  • 5. Arthritis mutilans in a patient with systemic lupus erythematosus and rheumatoid arthritis.
    Jakez-Ocampo J; Paulìn-Vera CM; Llorente L
    Joint Bone Spine; 2010 Jul; 77(4):374-5. PubMed ID: 20478723
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis.
    Petri M
    Lupus; 1996 Jun; 5 Suppl 1():S16-22. PubMed ID: 8803905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why all systemic lupus erythematosus patients should be given hydroxychloroquine treatment?
    Costedoat-Chalumeau N; Leroux G; Piette JC; Amoura Z
    Joint Bone Spine; 2010 Jan; 77(1):4-5. PubMed ID: 20022788
    [No Abstract]   [Full Text] [Related]  

  • 8. [Psoriasis and systemic lupus erythematosus: a rare association with specific therapeutic problems].
    Astudillo L; Sailler L; Carreiro M; Dahan S; Ollier S; Arlet P
    Ann Med Interne (Paris); 2003 Feb; 154(1):3-6. PubMed ID: 12746653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine alone for severe immune thrombocytopenic purpura associated with systemic lupus erythematosus.
    Blasco LM
    Lupus; 2013 Jun; 22(7):752-3. PubMed ID: 23698017
    [No Abstract]   [Full Text] [Related]  

  • 10. Methotrexate in systemic lupus erythematosus.
    Walz LeBlanc BA; Dagenais P; Urowitz MB; Gladman DD
    J Rheumatol; 1994 May; 21(5):836-8. PubMed ID: 8064722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise.
    Tench CM; McCarthy J; McCurdie I; White PD; D'Cruz DP
    Rheumatology (Oxford); 2003 Sep; 42(9):1050-4. PubMed ID: 12730519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the functional assessment of chronic illness therapy-fatigue scale in patients with moderately to severely active systemic lupus erythematosus, participating in a clinical trial.
    Lai JS; Beaumont JL; Ogale S; Brunetta P; Cella D
    J Rheumatol; 2011 Apr; 38(4):672-9. PubMed ID: 21239746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of physical exercise in a population with systemic lupus erythematosus: A systematic review].
    Ayán C; de Pedro-Múñez A; Martínez-Lemos I
    Semergen; 2018 Apr; 44(3):192-206. PubMed ID: 29439911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of hydroxychloroquine in Japan.
    Kishimoto M; Deshpande GA; Yokogawa N; Buyon JP; Okada M
    J Rheumatol; 2012 Jun; 39(6):1296. PubMed ID: 22661421
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic lupus erythematosus.
    Madhok R; Wu O
    Am Fam Physician; 2007 Nov; 76(9):1351-3. PubMed ID: 18019880
    [No Abstract]   [Full Text] [Related]  

  • 16. Hydroxychloroquine-induced pigmentation in two patients with systemic lupus erythematosus.
    Reynaert S; Setterfield J; Black MM
    J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):487-8. PubMed ID: 16643169
    [No Abstract]   [Full Text] [Related]  

  • 17. Systemic lupus erythematosus and psoriasis: a new case.
    Ben Dhaou B; Aydi Z; Baili L; Ketari S; Boussema F; Rokbani L
    Tunis Med; 2013 Dec; 91(12):737. PubMed ID: 24458680
    [No Abstract]   [Full Text] [Related]  

  • 18. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with blood hydroxychloroquine level in lupus patients: renal function could be important.
    Lee JY; Luc S; Greenblatt DJ; Kalish R; McAlindon TE
    Lupus; 2013 Apr; 22(5):541-2. PubMed ID: 23396569
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroxychloroquine myopathy.
    Richards AJ
    J Rheumatol; 1998 Aug; 25(8):1642-3. PubMed ID: 9712114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.